The recent BMJ Oncology study finds that using MRI screenings based on age can effectively identify prostate cancer risks independent of traditional PSA levels. The findings suggest that an MRI-based approach could be a more accurate alternative for prostate cancer screening, particularly for men with PSA levels lower than 3.0 ng/mL.
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting – Biotech Investments
Relief Therapeutics Holding SA / Key word(s): AGMEGM RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting 26.04.2024 / 17:30 CET/CEST RELIEF THERAPEUTICS Holding